ADIAL PHARMACEUTICALS, INC.（ADIL）内部人交易：高管与董事近期交易
过去 18 个月，共有 7 位内部人为 ADIAL PHARMACEUTICALS, INC.（ADIL）报告了 15 笔 Form 4 交易（最近一笔 2026-07-16）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-16 | Coastlands Capital LP | 10% 以上股东 | 买入 | 2,000 | $5,300 |
| 2026-07-16 | Coastlands Capital LP | 10% 以上股东 | 买入 | 1,233 | $3,391 |
| 2026-07-13 | Coastlands Capital LP | 10% 以上股东 | 买入 | 10,053 | $28,048 |
| 2026-07-13 | Coastlands Capital LP | 10% 以上股东 | 买入 | 1,700 | $4,590 |
| 2026-07-01 | Coastlands Capital LP | 10% 以上股东 | 买入 | 25,000 | $65,000 |
| 2026-06-16 | Davidson Matt | Chief Development Officer | 买入 | 61,647 | $0 |
| 2026-06-16 | Davidson Matt | Chief Development Officer | 买入 | 3,427 | $0 |
| 2026-06-16 | Davidson Matt | Chief Development Officer | 买入 | 232,417 | $0 |
| 2026-06-16 | Davidson Matt | Chief Development Officer | 买入 | 1,822 | $0 |
| 2026-06-16 | Davidson Matt | Chief Development Officer | 买入 | 101 | $0 |
| 2026-04-09 | Claiborne Cary J | Chief Executive Officer | 买入 | 37,985 | $0 |
| 2026-04-09 | Gilliland Robertson H. | 董事 | 买入 | 9,185 | $0 |
| 2026-04-09 | Goodman Tony | Chief Operating Officer | 买入 | 26,510 | $0 |
| 2026-04-09 | Schuyler Kevin | 董事 | 买入 | 9,185 | $0 |
| 2026-04-09 | Shah Vinay | Chief Financial Officer | 买入 | 17,325 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-07-16